GlassScriptPhysician profile
Razvan Iorga
NPI 1841853371
$3,561.82
in general payments reported to CMS, 2019-2025
8 companies · $99.14 in 2025
The $99.14 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.63 · 2024: $3,445 · 2025: $99.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $675 · Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $675.28 |
| Food and Beverage | $368.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,410.80 | 2024 | |
| Abbvie INC. | $41.00 | 2024-2025 | |
| Biowound Solutions, INC. | $23.28 | 2025 | Bio-Connekt |
| Biocomposites INC | $19.25 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $18.42 | 2025 | Exparel |
| Smith+Nephew, INC. | $17.63 | 2020 | |
| Solventum Corporation | $16.33 | 2024 | Prevena |
| Braintree Laboratories, INC. | $15.11 | 2025 | Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Razvan Iorga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.